A. D’avolio

Vitamin D in the COVID 19 prevention and treatment: emerging evidence

G. Isaia, A. D’avolio, 2021 .

Influence of single-nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness

A. Piga, A. D’Avolio, J. Cusato, 2014, The Pharmacogenomics Journal.

Tenofovir Clearance is Reduced in HIV-positive Patients with Subclinical Tubular 31 Impairment 32 33

Trentini, G. Mengozzi, Calcagno, 2022 .

Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics.

L. Calza, G. Guaraldi, G. di Perri, 2015, Current HIV research.

Pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers.

A. Winston, L. Dickinson, J. Ashby, 2011, The Journal of antimicrobial chemotherapy.

Differential Dose Adjustments of Immunosuppressants after Resuming Boosted versus Unboosted HIV‐Protease Inhibitors Postliver Transplant

G. Guaraldi, F. di Benedetto, S. Cocchi, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.